Department of Surgery »  Faculty »  Chris E. Freise, M.D.

Chris E. Freise, M.D.

Professor & Interim Division Chief
Division of Transplant Surgery

Contact Information

(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-9321 Academic
Chris.Freise@ucsf.edu
Open Popup
  • University of Minnesota, B.A., Chemistry, 1978-82
  • University of Minnesota, M.D., 1982-86
  • University of Minnesota, Intern, Surgery, 1986-87
  • University of Minnesota, Resident, Surgery, 1987-89
  • University of Minnesota, Resident, Surgery, 1992-93
  • University of Minnesota, Chief Resident, Surgery, 1993-94
  • University of California, San Francisco, Fellow, Surgery, 1989-92
  • University of California, San Francisco, Fellow, Transplant Surgery, 1994-96
  • American Board of Surgery, 1995
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Cholangiocarcinoma (Bile Duct Cancer)
  • Choledochal Cyst Disease
  • Dialysis Access
  • Expanded Criteria Donor Kidney Transplantation
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Intestinal Transplantation and Rehabilitation
  • Kidney and LIver Transplantation in HIV Patients
  • Kidney Auto-transplantation
  • Kidney Transplantation
  • Laparoscopic Donor Nephrectomy
  • Laparoscopic Kidney and Liver Surgery
  • Liver Transplantation
  • Living Donor Kidney Transplantation
  • Living Donor Liver Transplantation
  • Pancreas Transplantation
  • Pediatric Kidney Transplantation
  • Pediatric Liver Transplantation
  • Polycystic Kidney Disease
  • Polycystic Liver Disease
  • Portal Hypertension
  • Surgical Shunts
  • Delivery of Immunosuppressive Agents to Organ Allografts
  • Improvement Organ Function in Deceased Donors
  • Ischemia Reperfusion Injury

Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

Highly respected by his peers, Dr. Freise was named to the list of U.S. News "Top Doctors," which denotes the top 10% of physicians within a region practicing a given specialty. He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

Most recent publications from a total of 114
  1. DiMartini A, Dew MA, Liu Q, Simpson MA, Ladner DP, Smith AR, Zee J, Abbey S, Gillespie BW, Weinrieb R, Mandell MS, Fisher RA, Emond JC, Freise CE, Sherker AH, Butt Z. Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2). Am J Transplant. 2016 Sep 20. View in PubMed
  2. Dew MA, DiMartini AF, Ladner DP, Simpson MA, Pomfret EA, Gillespie BW, Merion RM, Zee J, Smith AR, Holtzman S, Sherker AH, Weinrieb R, Fisher RA, Emond JC, Freise CE, Burton JR, Butt Z. Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study. Transplantation. 2016 Jun; 100(6):1257-69. View in PubMed
  3. Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation. Transplantation. 2016 Jun; 100(6):1244-50. View in PubMed
  4. Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM. Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study. Am J Transplant. 2016 Feb; 16(2):594-602. View in PubMed
  5. Hecht E, Freise C, Websky KV, Nasser H, Kretzschmar N, Stawowy P, Hocher B, Querfeld U. The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant. 2016 May; 31(5):789-97. View in PubMed
  6. Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015 Sep; 262(3):465-75; discussion 473-5. View in PubMed
  7. Freise C, Kim KY, Querfeld U. A Lindera obtusiloba Extract Blocks Calcium-/Phosphate-Induced Transdifferentiation and Calcification of Vascular Smooth Muscle Cells and Interferes with Matrix Metalloproteinase-2 and Metalloproteinase-9 and NF-?B. Evid Based Complement Alternat Med. 2015; 2015:679238. View in PubMed
  8. Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2015 Jan; 21(1):79-88. View in PubMed
  9. Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS, Merion RM, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Burton JR, Shaked A, Butt Z. Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). J Hepatol. 2015 Feb; 62(2):346-53. View in PubMed
  10. Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience. Liver Transpl. 2014 Oct; 20(10):1202-10. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Chris E. Freise, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.
  • Sheila FitzPatrick

    Due Diligence Pays Off

    Sheila Fitzpatrick.jpg
    An international attorney specializing in data privacy and employment law, Sheila FitzPatrick spent three weeks of every month hopscotching the globe. Curious and passionate, she nurtured a worldwide network of friends who became her second family. A self-described "super-active" person, she loved heart-pounding 2-mile swims in the morning and long, leisurely walks around the great cities of Europe. She approached staying healthy with the same drive. Regular checkups never revealed the slightest hint of kidney disease. But in 2008, her[...]
    Story Categories: DialysisEnd-Stage Renal Disease (ESRD)Kidney Transplant
  • Frank Jimenez

    Daughter Donates Kidney to Father

    Frank Jimenez was 73 years old when he learned his kidneys were failing, but he wasn't exactly used to feeling sick and tired. For decades he'd worked 10 to 12 hour days, running his theater supplies business. He was a lifelong athlete who built his own house in the countryside outside of Sonoma, Calif. His doctor had no idea what had caused his kidney failure, and he hadn't faced anything like it before. "I'd never been sick in my life," he says. "It was a shock." Frank worked hard to stay healthy and keep his kidneys going with a good diet,[...]
    Story Categories: Kidney TransplantLiving Donor Kidney Transplant

X